Tag: CORO
COVID-19 Tied to Higher Risk for New, Worsening Bladder Symptoms
Symptomatic infection tied to three times greater risk for developing new or worsening overactive bladder symptoms
COVID-19 mRNA Vaccines Tied to Higher Risk for Myocarditis, Pericarditis
Authors say benefits of vaccination still outweigh risks, but some individuals should be aware of their higher risk
Second, Third COVID-19 Vaccine May Up Relapse in Glomerular Disease
Absolute increase in 30-day relapse risk associated with the second or third vaccine dose is small
Pfizer Study Reveals Big Rise in Immunity From COVID-19 Booster
FDA says findings affirm its decision to approve the booster without human testing based on experience with a similarly tweaked vaccine
Infant SARS-CoV-2 Infection Uncommon After In Utero Exposure
All-cause mortality higher for infants born to women with SARS-CoV-2 infection ≤14 days versus >14 days before delivery
Long COVID Prevalent in U.S. Adults With Prior COVID-19 Infection
Prevalence estimated to be almost 15 percent; risk higher for older adults and women and lower with completion of primary vaccination series before infection
Omicron BA.2 Subvariant Less Severe Than Delta, Original Omicron
Mortality rates lower for omicron BA.2 than for delta variant and omicron B.1.1.529
Disparities ID’d in Dispensing of Oral Antivirals for COVID-19
Substantial disparities seen in dispensing rates in high social-vulnerability zip codes versus medium-, low-vulnerability zip codes
Pooled Risk for Thrombocytopenia Increased After ChAdOx1-S Vaccine
Pooled 30 percent increased risk for thrombocytopenia seen after first dose of ChAdOx1-S versus BNT162b2
Overall Symptoms After BNT162b2, Other Vaccines Comparable in <5s
Injection-site, musculoskeletal, dermatologic, otolaryngologic symptoms more frequent; general symptoms and fever less frequent with BNT162b2 in children younger than 5 years of age
